Evidence map›Paper›PMID 40599187›Full record

ReviewWorld journal of gastroenterology2025

Pay attention to the value of liver regeneration in the re-compensation of decompensated cirrhosis.

Jia-Ying Wang, Bo Yi, Chun-Yan Li, Hua-Qian Xu, Shan-Hong Tang

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jia-Ying WangDepartment of Gastroenterology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu 610083, Sichuan Province, China.
Bo YiDepartment of Gastroenterology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu 610083, Sichuan Province, China.
Chun-Yan LiDepartment of Gastroenterology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu 610083, Sichuan Province, China.
Hua-Qian XuDepartment of Gastroenterology, Chinese People's Liberation Army Western Theater General Hospital, Chengdu 610083, Sichuan Province, China.
Shan-Hong TangDepartment of Gastroenterology, Western Theater Command General Hospital, Chengdu 610083, Sichuan Province, China. tangshanhong@swjtu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional wisdom holds that progression from compensated cirrhosis to decompensated cirrhosis is irreversible in the natural history of the disease. However, in recent years, more and more clinical evidence suggests that liver cirrhosis can achieve re-compensation, that is, after effective etiological treatment and complication management, the liver function of partially decompensated patients with cirrhosis has improved and gradually stabilized, and decompensation no longer occurs for a long time. Liver regeneration, as one of the powerful intrinsic abilities of the liver, is the key to the restoration of the structure and complex physiological functions of the damaged liver. Studies have shown that the restoration of liver regeneration in patients with cirrhosis can promote the occurrence of re-compensation, thereby improving the prognosis of patients. At the same time, monitoring liver regeneration indicators is helpful in assessing patients' re-compensation potential for early selection of appropriate treatment options. Insufficient attention has been paid to the role of liver regeneration in the course of liver cirrhosis. Therefore, this article aims to review the value of liver regeneration in the re-compensation of decompensated cirrhosis.

Indexed as

LiverLiver CirrhosisLiver RegenerationDisease ProgressionHumansPrognosisTreatment OutcomeDecompensated cirrhosisLiver regenerationPrognosisRe-compensationα-fetoprotein

Identifiers

PMID40599187
PMCPMC12207540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.